KRTL Holding Group, Inc. (KRTL)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Biotechnology Research and Development	2.67M
Biotechnology Research and Development Growth	8172.74%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
United States	2.67M
United States Growth	8172.74%